Hybrid capture-based comprehensive genomic profiling identifies lung cancer patients with well-characterized sensitizing epidermal growth factor receptor point mutations that were not detected by standard of care testing - Suh, J H; Schrock, A B; Johnson, A (Oncologist, 2018)
, et al.